218 related articles for article (PubMed ID: 30410040)
1. Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study.
Sterling RK; Wahed AS; King WC; Kleiner DE; Khalili M; Sulkowski M; Chung RT; Jain MK; Lisker-Melman M; Wong DK; Ghany MG;
Am J Gastroenterol; 2019 May; 114(5):746-757. PubMed ID: 30410040
[TBL] [Abstract][Full Text] [Related]
2. A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV-HIV Co-infected Adults in North America.
Sterling RK; King WC; Khalili M; Chung RT; Sulkowski M; Jain MK; Lisker-Melman M; Ghany MG; Wong DK; Hinerman AS; Bhan AK; Wahed AS; Kleiner DE;
Hepatology; 2021 Sep; 74(3):1174-1189. PubMed ID: 33743541
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians.
Grant J; Agbaji O; Kramvis A; Yousif M; Auwal M; Penugonda S; Ugoagwu P; Murphy R; Hawkins C
Trop Med Int Health; 2017 Jun; 22(6):744-754. PubMed ID: 28376292
[TBL] [Abstract][Full Text] [Related]
4. Liver function test abnormalities in Nigerian patients with human immunodeficiency virus and hepatitis B virus co-infection.
Iroezindu MO; Agbaji OO; Daniyam CA; Isiguzo GC; Isichei C; Akanbi MO
Int J STD AIDS; 2013 Jun; 24(6):461-7. PubMed ID: 23970749
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM).
Liégeois F; Boyer S; Eymard-Duvernay S; Carrieri P; Kouanfack C; Domyeum J; Maradan G; Ducos J; Mpoudi-Ngolé E; Spire B; Delaporte E; Kuaban C; Vidal L; Laurent C;
BMC Infect Dis; 2020 Jan; 20(1):49. PubMed ID: 31941464
[TBL] [Abstract][Full Text] [Related]
6. Immunological and virological responses to cART in HIV/HBV co-infected patients from a multicenter cohort.
Wang H; Li Y; Zhang C; Han Y; Zhang X; Zhu T; Li T
AIDS; 2012 Sep; 26(14):1755-63. PubMed ID: 22614885
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and predictors of liver disease in HIV-infected children and adolescents.
Pokorska-Śpiewak M; Stańska-Perka A; Popielska J; Ołdakowska A; Coupland U; Zawadka K; Szczepańska-Putz M; Marczyńska M
Sci Rep; 2017 Sep; 7(1):12309. PubMed ID: 28951598
[TBL] [Abstract][Full Text] [Related]
8. More improvement than progression of liver fibrosis following antiretroviral therapy in a longitudinal cohort of HIV-infected patients with or without HBV and HCV co-infections.
Ding Y; Duan S; Ye R; Yang Y; Yao S; Wang J; Cao D; Liu X; Lu L; Jia M; Wu Z; He N
J Viral Hepat; 2017 May; 24(5):412-420. PubMed ID: 27925409
[TBL] [Abstract][Full Text] [Related]
9. CD4
Li X; Xu L; Lu L; Liu X; Yang Y; Wu Y; Han Y; Li X; Li Y; Song X; Cao W; Li T
Front Cell Infect Microbiol; 2023; 13():1178788. PubMed ID: 37207191
[TBL] [Abstract][Full Text] [Related]
10. Elevated pre-treatment IL-18 level is associated with HBeAg seroconversion in HIV-HBV coinfection.
Li Y; Xie J; Wang H; Han Y; Wang N; Thio CL; Li T
Antivir Ther; 2017; 22(6):523-527. PubMed ID: 28195558
[TBL] [Abstract][Full Text] [Related]
11. Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study.
Boyd A; Bottero J; Miailhes P; Lascoux-Combe C; Rougier H; Girard PM; Serfaty L; Lacombe K
J Int AIDS Soc; 2017 Feb; 20(1):21426. PubMed ID: 28362068
[TBL] [Abstract][Full Text] [Related]
12. Longer duration of HBV-active antiretroviral therapy is linked to favorable virological outcome in HIV-HBV co-infected patients.
Lee T; Núñez M
HIV Clin Trials; 2009; 10(3):153-9. PubMed ID: 19632954
[TBL] [Abstract][Full Text] [Related]
13. Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared.
Wandeler G; Mulenga L; Vinikoor MJ; Kovari H; Battegay M; Calmy A; Cavassini M; Bernasconi E; Schmid P; Bolton-Moore C; Sinkala E; Chi BH; Egger M; Rauch A;
Int J Infect Dis; 2016 Oct; 51():97-102. PubMed ID: 27596685
[TBL] [Abstract][Full Text] [Related]
14. Combination Antiretroviral Therapy Is Associated With Reduction in Liver Fibrosis Scores in HIV-1-Infected Subjects.
Li Y; Xie J; Han Y; Wang H; Lv W; Guo F; Qiu Z; Li Y; Du S; Song X; Zhu T; Thio CL; Li T
Medicine (Baltimore); 2016 Feb; 95(5):e2660. PubMed ID: 26844493
[TBL] [Abstract][Full Text] [Related]
15. Risk of Liver Fibrosis in Hepatitis B Virus and HIV Coinfected Youths Receiving Tenofovir-Containing Antiretroviral Regimen.
Aurpibul L; Kanjanavanit S; Leerapun A; Puthanakit T
J Int Assoc Provid AIDS Care; 2019; 18():2325958218823259. PubMed ID: 30798669
[TBL] [Abstract][Full Text] [Related]
16. Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono-infection.
Lieveld FI; Smit C; Richter C; van Erpecum KJ; Spanier BWM; Gisolf EH; Vrolijk JM; Siersema PD; Hoepelman AIM; Reiss P; Arends JE
Liver Int; 2019 Mar; 39(3):470-483. PubMed ID: 30411848
[TBL] [Abstract][Full Text] [Related]
17. Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection.
Huang YS; Chang SY; Sheng WH; Sun HY; Lee KY; Chuang YC; Su YC; Liu WC; Hung CC; Chang SC
PLoS One; 2016; 11(12):e0169228. PubMed ID: 28033344
[TBL] [Abstract][Full Text] [Related]
18. Association between hepatitis B co-infection and elevated liver stiffness among HIV-infected adults in Lusaka, Zambia.
Vinikoor MJ; Mulenga L; Siyunda A; Musukuma K; Chilengi R; Moore CB; Chi BH; Davies MA; Egger M; Wandeler G;
Trop Med Int Health; 2016 Nov; 21(11):1435-1441. PubMed ID: 27499385
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.
Boyd A; Maylin S; Moh R; Mahjoub N; Gabillard D; Eholié SP; Danel C; Anglaret X; Zoulim F; Girard PM; Delaugerre C; Lacombefor K;
J Gastroenterol Hepatol; 2016 Mar; 31(3):634-44. PubMed ID: 26313291
[TBL] [Abstract][Full Text] [Related]
20. Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfection.
Huang YS; Sun HY; Chang SY; Chuang YC; Cheng A; Huang SH; Huang YC; Chen GJ; Lin KY; Su YC; Liu WC; Hung CC
Hepatol Int; 2019 Jul; 13(4):431-439. PubMed ID: 31177505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
